2m 2m 2m 2m 2m 2m 2m
VERA THERAPEUT-A (VERA)
NASDAQ
$41.03-$0.47 (-1.13%)
Price as of Jul 14, 2026 5:04 AM EDT- $3.0BMarket Cap
- 74.52%1-Year Change
- BiotechnologyIndustry
VERA THERAPEUT-A (VERA)
$41.03-$0.47 (-1.13%)
VERA | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $41.50 | ||
Change | -$0.50 (-1.19%) | ||
Open | $41.26 | ||
High | $41.86 | ||
Low | $39.81 | ||
Previous Close | $42.00 | ||
Volume | 2,233,823 | ||
30-Day Average Volume | 2,659,195 | ||
1-Week Change | 3.41% | ||
1-Month Change | 21.13% | ||
1-Year Change | 74.52% | ||
3-Year Change | 146.88% | ||
5-Year Change | 179.09% | ||
Fundamentals | |||
Shares Outstanding | 71.8M | ||
Total Assets | $621.7M | ||
Market Cap | $3.0B | ||
Enterprise Value | $2.9B | ||
Period: QTR TTM FY | |||
Revenue | -$942,000.00 | ||
Net Income | -$121.0M | ||
Free Cash Flow | -$106.5M | ||
EBIT | -$121.0M | ||
EBITDA | -$120.9M | ||
Net Working Capital | $570.7M | ||
EPS | -$1.69 | ||
Enterprise Value/EBITDA | -24 | ||
Enterprise Value/Revenue | -3,121 | ||
P/B | 6 | ||
P/E | -25 | ||
PEG | 1 | ||
Price/Free Cash Flow | -28 | ||
Price/Operating Cash Flow | -28 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue